1. AB0545 Interferon Alpha2a versus Cyclosporin A for The Treatment of Severe Ocular Behcet's Disease – A Prospective, Randomised, Single Blind, National Multicenter Trial (INCYTOB). (15th July 2016) Authors: Kötter, I.; Vonthein, R.; Schoenfisch, B.; Xenitidis, T.; Doycheva, D.; Henes, J.; Stübiger, N.; Feist, E.; Heiligenhaus, A.; Rath, T.; Max, R.; Mackensen, F.; Altenburg, A.; Krause, L.; Zouboulis, C.; Blaschke, S.; Horn, M.; Neß, T.; Goldacker, S.; Deuter, C. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 1091 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SAT0455 Prevalence of behçet's disease in south-west germany among the adult turkish and german population. (23rd January 2014) Authors: Riewerts, F.; Henes, J.C.; Deuter, C.; Lorenz, H.-M.; Mackensen, F.; Döhner, H.; Peter, H.H.; Kötter, I. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 626 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Three Years of Experience with QuantiFERON-TB Gold Testing in Patients with Uveitis. (December 2014) Authors: Jakob, E.; Max, R.; Zimmermann, S.; Dalpke, A. H.; Alle, W.; Becker, M.; Mackensen, F. Journal: Ocular immunology and inflammation Issue: Volume 22:Number 6(2014) Page Start: 478 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗